Empagliflozin, an inhibitor of sodium-glucose co-transporter 2 (iSGLT2), improves cardiovascular outcomes in patients with and without diabetes and possesses an antiarrhythmic activity. However, the mechanisms of these protective effects have not been fully elucidated. This study aimed to explore the impact of empagliflozin on ion channel activity and electrophysiological characteristics in the ventricular myocardium.
View Article and Find Full Text PDFBackground: Brugada syndrome (BrS) is a rare inherited cardiac arrhythmia with increased risk of sudden cardiac death. Mutations in gene SCN5A, which encodes the α-subunit of cardiac voltage-gated sodium channel NaV1.5, have been identified in over 20% of patients with BrS.
View Article and Find Full Text PDFSmall G-proteins of Rho family modulate the activity of several classes of ion channels, including K channels Kv1.2, Kir2.1, and ERG; Ca channels; and epithelial Na channels.
View Article and Find Full Text PDFThe effect of small G-proteins of the Rho family on sodium current conducted by cardiac isoform Na1.5 of voltage-gated sodium channels was studied in heterologous expression system, CHO-K1 cell line transfected with a plasmid containing the Na1.5 gene.
View Article and Find Full Text PDFBiochim Biophys Acta Mol Basis Dis
November 2020
Background: Mutations in desmosomal genes linked to arrhythmogenic cardiomyopathy are commonly associated with Wnt/β-catenin signaling abnormalities and reduction of the sodium current density. Inhibitors of GSK3B were reported to restore sodium current and improve heart function in various arrhythmogenic cardiomyopathy models, but mechanisms underlying this effect remain unclear. We hypothesized that there is a crosstalk between desmosomal proteins, signaling pathways, and cardiac sodium channels.
View Article and Find Full Text PDF